Blue Owl Capital Holdings »

Liminatus Pharma shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4k 50k 0.15
2025-06-30 $12k 50k 0.24

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Engene Holdings (ENGN)
Larimar Therapeutics (LRMR)
Evercommerce (EVCM)
Holley (HLLY)
Roivant Sciences SHS (ROIV)
Cullinan Oncology (CGEM)
Ultragenyx Pharmaceutical (RARE)
Conduent Incorporate (CNDT)
Sagimet Biosciences Com Ser A (SGMT)
Compass Therapeutics (CMPX)
Dell Technologies CL C (DELL)
Civeo Corp Cda Com New (CVEO)
Context Therapeutics (CNTX)

View all positions for Blue Owl Capital Holdings

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma